UnitedHealth Price Target Lifted to $440 at Mizuho: The Managed Care Storm Clouds Are Clearing

Mizuho increased its UnitedHealth Group price target to $440 from $410 while maintaining an Outperform rating. The change followed a sector-wide reset that lifted price targets across five major insurers. The update reflects improved confidence that medical loss ratio pressures are easing and that negative MLR shifts are less likely through the end of 2026. UnitedHealth’s Q1 results were described as solid, with adjusted EPS of $7.23 versus a $6.61 consensus and an improved medical care ratio to 84%. Management raised full-year 2026 adjusted EPS guidance to greater than $18.25. The stock has rebounded, and valuation metrics suggest expectations for an earnings recovery.

"Mizuho raised its price target on UnitedHealth Group to $440 from $410 and kept an Outperform rating on the managed care leader. The call is part of a sector-wide constructive reset by the firm, with price targets lifted across five major insurers on the same day. For watchful investors, the message is that the rolling storm of medical loss ratio (MLR) shocks that battered managed care in 2025 may finally be passing."

"The revised UnitedHealth Group stock target sits well above the $389.19 consensus analyst target, signaling Mizuho is now positioned ahead of the broader Street. The upgrade reflects growing confidence that medical cost pressures are easing across the sector. Mizuho views Q1 reports across the managed care group as solid and cites a reduced likelihood of negative medical loss ratio shifts through the end of 2026."

"UnitedHealth Group is the largest U.S. managed care company, with a market capitalization near $353 billion and UnitedHealthcare contributing 80% of group revenue. Q1 2026 adjusted EPS came in at $7.23 against a $6.61 consensus, with the medical care ratio improving 90 basis points to 84%. UnitedHealth's management raised its full-year 2026 adjusted EPS guidance to greater than $18.25, up from the prior $17.75 floor set in January."

"UnitedHealth stock has staged a sharp recovery, with shares up 17% year to date and 20% over the past month. The forward P/E ratio of 22x compared to a trailing P/E ratio of 29x reflects expectations of meaningful earnings rebuild. The MLR easing also matters because 2025 adjusted medical care ratio (MCR) ran at 89% after Medicare funding cuts and elevated utilization compressed margins."

Read at 24/7 Wall St.